Physician profile
Keren Fogelfeld
NPI 1215185038
$6,262.90
in general payments reported to CMS, 2019-2025
30 companies · $4,947 in 2025
The $4,947 reported for 2025 was more than what 93% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $81.71 · 2023: $280 · 2024: $629 · 2025: $4,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,055 · Food and Beverage: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,054.99 |
| Food and Beverage | $1,800.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,000.00 | 2025 | |
| Glaxosmithkline, LLC. | $297.44 | 2025 | Nucala, Trelegy Ellipta |
| Harmony Biosciences LLC | $212.34 | 2023-2024 | Wakix |
| Amgen INC. | $211.45 | 2023-2025 | Tezspire |
| Insmed, INC. | $163.05 | 2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $156.17 | 2024-2025 | Tyvaso, Tyvaso |
| Astrazeneca Pharmaceuticals Lp | $143.47 | 2024-2025 | Tezspire, Fasenra |
| Philips North America LLC | $111.63 | 2023-2025 | (8874) Incourage, Sleep Service |
| Actelion Pharmaceuticals US, INC. | $110.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $94.51 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $93.84 | 2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $86.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.60 | 2019-2024 | Winrevair |
| Viatris Specialty LLC | $76.33 | 2025 | Yupelri |
| Electromed, INC. | $41.40 | 2024-2025 | Smartvest |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $36.84 | 2025 | Photofrin |
| Atos Medical INC | $35.79 | 2024 | Provox Life Home Hme |
| Baxter Healthcare | $34.70 | 2023 | Hillrom - Life 2000 Ventilation System |
| Olympus America INC. | $30.39 | 2023 | Evis Exera III Bronchovideoscope |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.54 | 2024 | Ofev |
| Medtronic, INC. | $29.41 | 2024 | Puritan Bennett |
| Mylan Specialty L.P. | $26.82 | 2024 | Yupelri |
| La Jolla Pharmaceutical Company | $24.96 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.19 | 2019 | |
| Genentech USA, INC. | $22.35 | 2020 | |
| Genzyme Corporation | $22.00 | 2025 | |
| Jazz Pharmaceuticals INC. | $20.95 | 2024 | |
| Azurity Pharmaceuticals, INC. | $17.65 | 2025 | Alvesco |
| Gilead Sciences, INC. | $16.43 | 2019 | |
| Allergan, INC. | $16.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keren Fogelfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.